Amphastar Pharmaceuticals Long Term Debt 2012-2024 | AMPH
Amphastar Pharmaceuticals long term debt from 2012 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Amphastar Pharmaceuticals Annual Long Term Debt
(Millions of US $) |
| 2023 |
$590 |
| 2022 |
$73 |
| 2021 |
$75 |
| 2020 |
$34 |
| 2019 |
$39 |
| 2018 |
$32 |
| 2017 |
$41 |
| 2016 |
$32 |
| 2015 |
$30 |
| 2014 |
$36 |
| 2013 |
$10 |
| 2012 |
$16 |
| 2011 |
$ |
| 2009 |
$ |
Amphastar Pharmaceuticals Quarterly Long Term Debt
(Millions of US $) |
| 2024-06-30 |
$587 |
| 2024-03-31 |
$594 |
| 2023-12-31 |
$590 |
| 2023-09-30 |
$638 |
| 2023-06-30 |
$488 |
| 2023-03-31 |
$73 |
| 2022-12-31 |
$73 |
| 2022-09-30 |
$74 |
| 2022-06-30 |
$74 |
| 2022-03-31 |
$74 |
| 2021-12-31 |
$75 |
| 2021-09-30 |
$76 |
| 2021-06-30 |
$30 |
| 2021-03-31 |
$32 |
| 2020-12-31 |
$34 |
| 2020-09-30 |
$33 |
| 2020-06-30 |
$35 |
| 2020-03-31 |
$36 |
| 2019-12-31 |
$39 |
| 2019-09-30 |
$38 |
| 2019-06-30 |
$40 |
| 2019-03-31 |
$31 |
| 2018-12-31 |
$32 |
| 2018-09-30 |
$33 |
| 2018-06-30 |
$34 |
| 2018-03-31 |
$40 |
| 2017-12-31 |
$41 |
| 2017-09-30 |
$42 |
| 2017-06-30 |
$40 |
| 2017-03-31 |
$31 |
| 2016-12-31 |
$32 |
| 2016-09-30 |
$34 |
| 2016-06-30 |
$32 |
| 2016-03-31 |
$29 |
| 2015-12-31 |
$30 |
| 2015-09-30 |
$31 |
| 2015-06-30 |
$35 |
| 2015-03-31 |
$36 |
| 2014-12-31 |
$36 |
| 2014-09-30 |
$41 |
| 2014-06-30 |
$43 |
| 2014-03-31 |
$10 |
| 2013-12-31 |
$10 |
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
$16 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.469B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
